TY - JOUR
T1 - Enhanced identification of postoperative infections among inpatients
AU - Yokoe, Deborah S.
AU - Noskin, Gary A.
AU - Cunningham, Susan M.
AU - Zuccotti, Gianna
AU - Plaskett, Theresa
AU - Fraser, Victoria J.
AU - Olsen, Margaret A.
AU - Tokars, Jerome I.
AU - Solomon, Steven
AU - Perl, Trish M.
AU - Cosgrove, Sara E.
AU - Tilson, Richard S.
AU - Greenbaum, Maurice
AU - Hooper, David C.
AU - Sands, Kenneth E.
AU - Tully, John
AU - Herwaldt, Loreen A.
AU - Diekema, Daniel J.
AU - Wong, Edward S.
AU - Climo, Michael
AU - Platt, Richard
PY - 2004/11
Y1 - 2004/11
N2 - We evaluated antimicrobial exposure, discharge diagnoses, or both to identify surgical site infections (SSI). This retrospective cohort study in 13 hospitals involved weighted, random samples of records from 8,739 coronary artery bypass graft (CABG) procedures, 7,399 cesarean deliveries, and 6,175 breast procedures. We compared routine surveillance to detection through inpatient antimicrobial exposure (≥9 days for CABG, ≥2 days for cesareans, and ≥6 days for breast procedures), discharge diagnoses, or both. Together, all methods identified SSI after 7.4% of CABG, 5.0% of cesareans, and 2.0% of breast procedures. Antimicrobial exposure had the highest sensitivity, 88%-91%, compared with routine surveillance, 38%-64%. Diagnosis codes improved sensitivity of detection of antimicrobial exposure after cesareans. Record review confirmed SSI after 31% to 38% of procedures that met antimicrobial surveillance criteria. Sufficient antimicrobial exposure days, together with diagnosis codes for cesareans, identified more postoperative SSI than routine surveillance methods. This screening method was efficient, readily standardized, and suitable for most hospitals.
AB - We evaluated antimicrobial exposure, discharge diagnoses, or both to identify surgical site infections (SSI). This retrospective cohort study in 13 hospitals involved weighted, random samples of records from 8,739 coronary artery bypass graft (CABG) procedures, 7,399 cesarean deliveries, and 6,175 breast procedures. We compared routine surveillance to detection through inpatient antimicrobial exposure (≥9 days for CABG, ≥2 days for cesareans, and ≥6 days for breast procedures), discharge diagnoses, or both. Together, all methods identified SSI after 7.4% of CABG, 5.0% of cesareans, and 2.0% of breast procedures. Antimicrobial exposure had the highest sensitivity, 88%-91%, compared with routine surveillance, 38%-64%. Diagnosis codes improved sensitivity of detection of antimicrobial exposure after cesareans. Record review confirmed SSI after 31% to 38% of procedures that met antimicrobial surveillance criteria. Sufficient antimicrobial exposure days, together with diagnosis codes for cesareans, identified more postoperative SSI than routine surveillance methods. This screening method was efficient, readily standardized, and suitable for most hospitals.
UR - http://www.scopus.com/inward/record.url?scp=7644226425&partnerID=8YFLogxK
U2 - 10.3201/eid1011.040572
DO - 10.3201/eid1011.040572
M3 - Article
C2 - 15550201
AN - SCOPUS:7644226425
SN - 1080-6040
VL - 10
SP - 1924
EP - 1930
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 11
ER -